Therapeutic Solutions International Inc (TSOI)

[Book_Archer]

TSOI currently has 29 products it's working on. Using the average success rate from 2006-2015 of 9.6%, that means roughly 3 of those products would end up being approved by the FDA (https://www.bio.org/sites/default/files/legacy/bioorg/docs/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf).
If each product earns one-hundred million each year, which considering most of the diseases TSOI is working to create cures for are widespread diseases the number could easily be doubled or tripled, that would TSOI three-hundred million in revenue, and if using a net income of .25 the number turns into 75 million. If you multiply seventy million with the average PE ratio for the pharmaceutical industry, which is 22.48, that would give out 1,686,000,000 (http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html). Divide that by the number of outstanding shares that TSOI currently has, 1,656,544,305 shares, and that leaves us with a potential PPS of 1.02. Potential life-changer here.